128 related articles for article (PubMed ID: 10649594)
21. In vitro penetration through the skin layers of topically applied glucocorticoids.
Carrer V; Alonso C; Oliver MA; Coderch L
Drug Test Anal; 2018 Oct; 10(10):1528-1535. PubMed ID: 29788546
[TBL] [Abstract][Full Text] [Related]
22. Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid.
Wollina U
J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):82-4. PubMed ID: 11451337
[No Abstract] [Full Text] [Related]
23. Simultaneous HPLC Determination of Betamethasone Esters-Containing Mixtures: Analysis of Their Topical Preparations.
Hassib ST; Mahrouse MA; Elkady EF; Sayed RM
J Chromatogr Sci; 2018 Sep; 56(8):716-723. PubMed ID: 29800112
[TBL] [Abstract][Full Text] [Related]
24. The use of biodegradable microneedle patches to increase penetration of topical steroid for prurigo nodularis.
Shin JU; Kim JD; Kim HK; Kang HK; Joo C; Lee JH; Jeong DH; Song S; Chu H; Lee JS; Lee H; Lee KH
Eur J Dermatol; 2018 Feb; 28(1):71-77. PubMed ID: 29521638
[TBL] [Abstract][Full Text] [Related]
25. Plasma concentrations of betamethasone after topical application of betamethasone 17-valerate: comparison with oral administration.
Kubota K; Lo ES; Huttinot G; Andersen PH; Maibach HI
Br J Clin Pharmacol; 1994 Jan; 37(1):86-8. PubMed ID: 8148226
[TBL] [Abstract][Full Text] [Related]
26. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting.
Md S; Kuldeep Singh JKA; Waqas M; Pandey M; Choudhury H; Habib H; Hussain F; Hussain Z
Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological evaluation of a new topical preparation containing dextran sulphate and betamethasone 17-valerate.
Passarella E; Milanino R
Arzneimittelforschung; 1980; 30(4):647-51. PubMed ID: 6156688
[TBL] [Abstract][Full Text] [Related]
28. Development of an in vitro skin permeation model simulating atopic dermatitis skin for the evaluation of dermatological products.
Simonsen L; Fullerton A
Skin Pharmacol Physiol; 2007; 20(5):230-6. PubMed ID: 17587887
[TBL] [Abstract][Full Text] [Related]
29. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
Turnidge J
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S23-34. PubMed ID: 10528784
[TBL] [Abstract][Full Text] [Related]
30. In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate.
Kubota K; Maibach HI
J Pharm Sci; 1993 Oct; 82(10):1039-45. PubMed ID: 8254489
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients.
Lee MH; Kim HJ; Ha DJ; Paik JH; Kim HY
J Korean Med Sci; 2002 Aug; 17(4):518-23. PubMed ID: 12172049
[TBL] [Abstract][Full Text] [Related]
32. Deoxycholate hydrogels of betamethasone-17-valerate intended for topical use: In vitro and in vivo evaluation.
Senyiğit T; Tekmen I; Sönmez U; Santi P; Ozer O
Int J Pharm; 2011 Jan; 403(1-2):123-9. PubMed ID: 21047547
[TBL] [Abstract][Full Text] [Related]
33. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].
Täuber VU; Amin M; Fuchs P; Speck U
Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945
[TBL] [Abstract][Full Text] [Related]
34. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.
Schlupp P; Blaschke T; Kramer KD; Höltje HD; Mehnert W; Schäfer-Korting M
Skin Pharmacol Physiol; 2011; 24(4):199-209. PubMed ID: 21346400
[TBL] [Abstract][Full Text] [Related]
35. Allergic Contact Dermatitis Due to "Therapeutic Uses" of Tea Tree Oil on the Lips and Toenails.
Lauriola MM; Sena P; De Bitonto A; Corazza M
Dermatitis; 2021 May-Jun 01; 32(3):e40-e41. PubMed ID: 33332860
[No Abstract] [Full Text] [Related]
36. Sensitivity of different areas of the flexor aspect of the human forearm to corticosteroid-induced skin blanching.
Meyer E; Smith EW; Haigh JM
Br J Dermatol; 1992 Oct; 127(4):379-81. PubMed ID: 1419758
[TBL] [Abstract][Full Text] [Related]
37. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
[TBL] [Abstract][Full Text] [Related]
38. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
Szadurski J; Renz F; Gasser D
Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
[TBL] [Abstract][Full Text] [Related]
39. An RP-HPLC Method for the Stability-Indicating Analysis of Impurities of Both Fusidic Acid and Betamethasone-17-Valerate in a Semi-Solid Pharmaceutical Dosage Form.
Byrne J; Velasco-Torrijos T; Reinhardt R
J Chromatogr Sci; 2015 Oct; 53(9):1498-503. PubMed ID: 25896658
[TBL] [Abstract][Full Text] [Related]
40. Fusidic acid in dermatology: an updated review.
Schöfer H; Simonsen L
Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
